Breast Cancer Vaccine to Boost Anti-Tumor Immunity

An experimental vaccine against breast cancer safely generated a strong immune response to a key tumor protein, researchers from the University of Washington (UW) School of Medicine in Seattle report in a paper published by the journal JAMA Oncology. The findings suggest the vaccine may be able to treat different types of breast cancer.

Because this was not a randomized clinical trial, the results should be considered preliminary, but the findings are promising enough that the vaccine will now be evaluated in a larger, randomized clinical trial,” said lead author Dr. Mary “Nora” L. Disis, a UW professor of medicine, Division of Medical Oncology, and director of the Cancer Vaccine Institute.

You must be logged in to view this content.

Spread Of Mutated Coronavirus In Danish Mink

Denmark set off alarm bells this week with its announcement that it is culling the nation’s entire mink herd — the largest in the world — to stop spread of the SARS-CoV-2 virus in the prized fur species because of potentially dangerous mutationsInter-species jumps of viruses make scientists nervous — as do suggestions of potentially significant mutations that result from those jumps. In this case, Danish authorities say they’ve found some genetic changes that might undermine the effectiveness of Covid-19 vaccines currently in development. But is this latest twist in the Covid-19 saga reason to be deeply concerned?

This hits all the scary buttons,” noted Carl Bergstrom, an evolutionary biologist at the University of Washington. But Bergstrom and others argued that while the virus’s penchant for infecting mink bears watching, it isn’t likely to lead to a nightmare strain that is more effective at infecting peoplethan the current human virus.

I don’t believe that a strain which gets adapted to mink poses a higher risk to humans,” said Francois Balloux, director of University College London’s Genetics Institute. “We can never rule out anything, but in principle it shouldn’t. It should definitely not increase transmission. I don’t see any good reason why it should make the virus more severe,” he said.

Let’s take a look at what’s known about the Danish situation, why inter-species jumps make scientists nervous, whether the mutations are likely to affect vaccine effectiveness, and why Balloux thinks this situation is “fantastically interesting.” Denmark is the world’s largest producer of mink — by some estimates 40%. Unfortunately, mink are susceptible to the SARS-2 virus, a fact that came to light in April when the Netherlands reported outbreaks on mink farms there. Infected humans who work in the farms transmit the virus to captive minks, which are housed in close quarters ideal for rapid transmission from mink to mink.

 

Occasionally, the mink infect people — a phenomenon recorded in both the Netherlands and in Denmark. In a statement, the Danish Ministry of Environment and Food said the country would cull its entire herd — estimated to be about 17 million animals — after finding mutations in the viruses from the mink that it believes would allow those viruses to evade the immune protection generated by Covid-19 vaccines.

Source: https://www.statnews.com/

Eye Scanner Detects Molecular Aging in Humans

People often say that eyes are windows to the soul. Now it appears they may also be windows to human aging.  All people age, but individuals do so at different rates, some faster and others slower. While this observation is common knowledge, there is no universally accepted measure of biological aging. Numerous aging-related metrics have been proposed and tested, but no marker to date has been identified or noninvasive method developed that can accurately measure and track biological aging in individuals. In what is believed to be the first study of its kind,  researchers from the Boston University School of Medicine (BUSM)  have discovered that a specialized eye scanner that accurately measures spectroscopic signals from proteins in lens of the eye can detect and track biological aging in living humans.

According to the researchers, chronological age does not adequately measure individual variation in the rate of biological aging.

CLICK ON THE IMAGE TO ENJOY THE VIDEO

The absence of clinical tools and metrics to quantitatively evaluate how each person is aging at the molecular level represents a major impediment to understanding aging and maximizing health throughout life,” explains corresponding author Lee E. Goldstein, MD, PhD, associate professor of neurology at BUSM.

The lens contains proteins that accumulate aging-related changes throughout life. These lens proteins provide a permanent record of each person’s life history of aging. Our eye scanner can decode this record of how a person is aging at the molecular level.”

The researchers believe these results pave the way for a potentially transformative clinical tool for objective assessment and tracking of molecular aging in humans. “The framework for clinical implementation of this technology to measure molecular aging is similar to other recently adopted clinical biomarkers, including PET brain imaging for Alzheimer’s disease, bone densitometry for osteoporosis and serum blood tests for diabetes mellitus,” adds Dr. Goldstein, who also holds an appointment at Boston University College of Engineering.

While large test batteries incorporating composite metrics have been developed to track human aging, these are far removed from underlying molecular mechanisms of aging and are ill-suited for personalized longitudinal medical care. “By contrast, eye scanning technology that probes lens protein affords a rapid, noninvasive, objective technique for direct measurement of molecular aging that can be easily, quickly, and safely implemented at the point of care. Such a metric affords potential for precision medical care across the lifespan.”

The research team included investigators at Boston University College of Engineering and School of Public Health, Boston Children’s Hospital, Massachusetts General Hospital, Harvard Medical School and the University of Washington, Seattle.

The findings appear online in Journal of Gerontology: Biological Sciences.

Source: https://www.bumc.bu.edu/

How To Replace The Thick Glass Lenses by 2D Metalens

In optics, the era of glass lenses may be waning. In recent years, physicists and engineers have been designing, constructing and testing different types of ultrathin materials that could replace the thick glass lenses used today in cameras and imaging systems. Critically, these engineered lenses — known as metalenses — are not made of glass. Instead, they consist of materials constructed at the nanoscale into arrays of columns or fin-like structures. These formations can interact with incoming light, directing it toward a single focal point for imaging purposes.

But even though metalenses are much thinner than glass lenses, they still rely on “high aspect ratio” structures, in which the column or fin-like structures are much taller than they are wide, making them prone to collapsing and falling over. Furthermore, these structures have always been near the wavelength of light they’re interacting with in thickness — until now. In a paper published in the journal Nano Letters, a team from the University of Washington (UW) and the National Tsing Hua University in Taiwan announced that it has constructed functional metalenses that are one-tenth to one-half the thickness of the wavelengths of light that they focus. Their metalenses, which were constructed out of layered 2D materials, were as thin as 190 nanometers — less than 1/100,000ths of an inch thick.

This is the first time that someone has shown that it is possible to create a metalens out of 2D materials,” said senior and co-corresponding author Arka Majumdar, a UW assistant professor of physics and of electrical and computer engineering.

Their design principles can be used for the creation of metalenses with more complex, tunable features, added Majumdar, who is also a faculty researcher with the UW’s Molecular Engineering & Sciences Institute and Institute for Nano-Engineered Systems.

Source: https://www.washington.edu/